OTC Anti-Infective Products Industry Research Report 2023
Highlights
The global OTC Anti-Infective Products market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
North American market for OTC Anti-Infective Products is estimated to increase from $ million in 2022 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for OTC Anti-Infective Products is estimated to increase from $ million in 2022 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The major global manufacturers of OTC Anti-Infective Products include Bayer, GSK, Teva, Johnson & Johnson, NOVARTIS, MYLAN, Sun Pharma, CR SANJIU and Cipla, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
The global market for OTC Anti-Infective Products in Hospital Pharmacies is estimated to increase from $ million in 2022 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Antifungal, which accounted for % of the global market of OTC Anti-Infective Products in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2023 to 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for OTC Anti-Infective Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Anti-Infective Products.
The OTC Anti-Infective Products market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global OTC Anti-Infective Products market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OTC Anti-Infective Products manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by OTC Anti-Infective Products type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the OTC Anti-Infective Products are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
OTC Anti-Infective Products segment by Type
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the OTC Anti-Infective Products market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the OTC Anti-Infective Products market.
OTC Anti-Infective Products segment by Sales Channel
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the OTC Anti-Infective Products market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Anti-Infective Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of OTC Anti-Infective Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the OTC Anti-Infective Products industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Anti-Infective Products.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of OTC Anti-Infective Products manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of OTC Anti-Infective Products by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of OTC Anti-Infective Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by sales channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
The global OTC Anti-Infective Products market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
North American market for OTC Anti-Infective Products is estimated to increase from $ million in 2022 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for OTC Anti-Infective Products is estimated to increase from $ million in 2022 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The major global manufacturers of OTC Anti-Infective Products include Bayer, GSK, Teva, Johnson & Johnson, NOVARTIS, MYLAN, Sun Pharma, CR SANJIU and Cipla, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
The global market for OTC Anti-Infective Products in Hospital Pharmacies is estimated to increase from $ million in 2022 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Antifungal, which accounted for % of the global market of OTC Anti-Infective Products in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2023 to 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for OTC Anti-Infective Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Anti-Infective Products.
The OTC Anti-Infective Products market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global OTC Anti-Infective Products market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OTC Anti-Infective Products manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Bayer
- GSK
- Teva
- Johnson & Johnson
- NOVARTIS
- MYLAN
- Sun Pharma
- CR SANJIU
- Cipla
- Lingrui
Global markets are presented by OTC Anti-Infective Products type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the OTC Anti-Infective Products are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
OTC Anti-Infective Products segment by Type
- Antifungal
- Antibacterial
- Antiviral
- Antiseptics
- Others
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the OTC Anti-Infective Products market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the OTC Anti-Infective Products market.
OTC Anti-Infective Products segment by Sales Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the OTC Anti-Infective Products market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Anti-Infective Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of OTC Anti-Infective Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the OTC Anti-Infective Products industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Anti-Infective Products.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of OTC Anti-Infective Products manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of OTC Anti-Infective Products by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of OTC Anti-Infective Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by sales channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global OTC Anti-Infective Products Market Size (2018-2029) & (US$ Million)
2.2.2 Global OTC Anti-Infective Products Sales (2018-2029)
2.2.3 Global OTC Anti-Infective Products Market Average Price (2018-2029)
2.3 OTC Anti-Infective Products by Type
2.3.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 Antifungal
1.2.3 Antibacterial
1.2.4 Antiviral
1.2.5 Antiseptics
1.2.6 Others
2.4 OTC Anti-Infective Products by Sales Channel
2.4.1 Market Value Comparison by Sales Channel (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 Hospital Pharmacies
2.4.3 Retail Pharmacies
2.4.4 Online Pharmacies
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global OTC Anti-Infective Products Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global OTC Anti-Infective Products Sales (M Units) of Manufacturers (2018-2023)
3.3 Global OTC Anti-Infective Products Revenue of Manufacturers (2018-2023)
3.4 Global OTC Anti-Infective Products Average Price by Manufacturers (2018-2023)
3.5 Global OTC Anti-Infective Products Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of OTC Anti-Infective Products, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of OTC Anti-Infective Products, Product Type & Application
3.8 Global Manufacturers of OTC Anti-Infective Products, Date of Enter into This Industry
3.9 Global OTC Anti-Infective Products Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Bayer
4.1.1 Bayer Company Information
4.1.2 Bayer Business Overview
4.1.3 Bayer OTC Anti-Infective Products Sales, Revenue and Gross Margin (2018-2023)
4.1.4 Bayer OTC Anti-Infective Products Product Portfolio
4.1.5 Bayer Recent Developments
4.2 GSK
4.2.1 GSK Company Information
4.2.2 GSK Business Overview
4.2.3 GSK OTC Anti-Infective Products Sales, Revenue and Gross Margin (2018-2023)
4.2.4 GSK OTC Anti-Infective Products Product Portfolio
4.2.5 GSK Recent Developments
4.3 Teva
4.3.1 Teva Company Information
4.3.2 Teva Business Overview
4.3.3 Teva OTC Anti-Infective Products Sales, Revenue and Gross Margin (2018-2023)
4.3.4 Teva OTC Anti-Infective Products Product Portfolio
4.3.5 Teva Recent Developments
4.4 Johnson & Johnson
4.4.1 Johnson & Johnson Company Information
4.4.2 Johnson & Johnson Business Overview
4.4.3 Johnson & Johnson OTC Anti-Infective Products Sales, Revenue and Gross Margin (2018-2023)
4.4.4 Johnson & Johnson OTC Anti-Infective Products Product Portfolio
4.4.5 Johnson & Johnson Recent Developments
4.5 NOVARTIS
4.5.1 NOVARTIS Company Information
4.5.2 NOVARTIS Business Overview
4.5.3 NOVARTIS OTC Anti-Infective Products Sales, Revenue and Gross Margin (2018-2023)
6.5.4 NOVARTIS OTC Anti-Infective Products Product Portfolio
6.5.5 NOVARTIS Recent Developments
4.6 MYLAN
4.6.1 MYLAN Company Information
4.6.2 MYLAN Business Overview
4.6.3 MYLAN OTC Anti-Infective Products Sales, Revenue and Gross Margin (2018-2023)
4.6.4 MYLAN OTC Anti-Infective Products Product Portfolio
4.6.5 MYLAN Recent Developments
4.7 Sun Pharma
4.7.1 Sun Pharma Company Information
4.7.2 Sun Pharma Business Overview
4.7.3 Sun Pharma OTC Anti-Infective Products Sales, Revenue and Gross Margin (2018-2023)
4.7.4 Sun Pharma OTC Anti-Infective Products Product Portfolio
4.7.5 Sun Pharma Recent Developments
6.8 CR SANJIU
4.8.1 CR SANJIU Company Information
4.8.2 CR SANJIU Business Overview
4.8.3 CR SANJIU OTC Anti-Infective Products Sales, Revenue and Gross Margin (2018-2023)
4.8.4 CR SANJIU OTC Anti-Infective Products Product Portfolio
4.8.5 CR SANJIU Recent Developments
4.9 Cipla
4.9.1 Cipla Company Information
4.9.2 Cipla Business Overview
4.9.3 Cipla OTC Anti-Infective Products Sales, Revenue and Gross Margin (2018-2023)
4.9.4 Cipla OTC Anti-Infective Products Product Portfolio
4.9.5 Cipla Recent Developments
4.10 Lingrui
4.10.1 Lingrui Company Information
4.10.2 Lingrui Business Overview
4.10.3 Lingrui OTC Anti-Infective Products Sales, Revenue and Gross Margin (2018-2023)
4.10.4 Lingrui OTC Anti-Infective Products Product Portfolio
4.10.5 Lingrui Recent Developments
5 GLOBAL OTC ANTI-INFECTIVE PRODUCTS MARKET SCENARIO BY REGION
5.1 Global OTC Anti-Infective Products Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global OTC Anti-Infective Products Sales by Region: 2018-2029
5.2.1 Global OTC Anti-Infective Products Sales by Region: 2018-2023
5.2.2 Global OTC Anti-Infective Products Sales by Region: 2024-2029
5.3 Global OTC Anti-Infective Products Revenue by Region: 2018-2029
5.3.1 Global OTC Anti-Infective Products Revenue by Region: 2018-2023
5.3.2 Global OTC Anti-Infective Products Revenue by Region: 2024-2029
5.4 North America OTC Anti-Infective Products Market Facts & Figures by Country
5.4.1 North America OTC Anti-Infective Products Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America OTC Anti-Infective Products Sales by Country (2018-2029)
5.4.3 North America OTC Anti-Infective Products Revenue by Country (2018-2029)
5.4.4 United States
5.4.5 Canada
5.5 Europe OTC Anti-Infective Products Market Facts & Figures by Country
5.5.1 Europe OTC Anti-Infective Products Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe OTC Anti-Infective Products Sales by Country (2018-2029)
5.5.3 Europe OTC Anti-Infective Products Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific OTC Anti-Infective Products Market Facts & Figures by Country
5.6.1 Asia Pacific OTC Anti-Infective Products Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific OTC Anti-Infective Products Sales by Country (2018-2029)
5.6.3 Asia Pacific OTC Anti-Infective Products Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America OTC Anti-Infective Products Market Facts & Figures by Country
5.7.1 Latin America OTC Anti-Infective Products Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America OTC Anti-Infective Products Sales by Country (2018-2029)
5.7.3 Latin America OTC Anti-Infective Products Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa OTC Anti-Infective Products Market Facts & Figures by Country
5.8.1 Middle East and Africa OTC Anti-Infective Products Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa OTC Anti-Infective Products Sales by Country (2018-2029)
5.8.3 Middle East and Africa OTC Anti-Infective Products Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global OTC Anti-Infective Products Sales by Type (2018-2029)
6.1.1 Global OTC Anti-Infective Products Sales by Type (2018-2029) & (M Units)
6.1.2 Global OTC Anti-Infective Products Sales Market Share by Type (2018-2029)
6.2 Global OTC Anti-Infective Products Revenue by Type (2018-2029)
6.2.1 Global OTC Anti-Infective Products Sales by Type (2018-2029) & (US$ Million)
6.2.2 Global OTC Anti-Infective Products Revenue Market Share by Type (2018-2029)
6.3 Global OTC Anti-Infective Products Price by Type (2018-2029)
7 SEGMENT BY SALES CHANNEL
7.1 Global OTC Anti-Infective Products Sales by Sales Channel (2018-2029)
7.1.1 Global OTC Anti-Infective Products Sales by Sales Channel (2018-2029) & (M Units)
7.1.2 Global OTC Anti-Infective Products Sales Market Share by Sales Channel (2018-2029)
7.2 Global OTC Anti-Infective Products Revenue by Sales Channel (2018-2029)
6.2.1 Global OTC Anti-Infective Products Sales by Sales Channel (2018-2029) & (US$ Million)
6.2.2 Global OTC Anti-Infective Products Revenue Market Share by Sales Channel (2018-2029)
7.3 Global OTC Anti-Infective Products Price by Sales Channel (2018-2029)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 OTC Anti-Infective Products Value Chain Analysis
8.1.1 OTC Anti-Infective Products Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 OTC Anti-Infective Products Production Mode & Process
8.2 OTC Anti-Infective Products Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 OTC Anti-Infective Products Distributors
8.2.3 OTC Anti-Infective Products Customers
9 GLOBAL OTC ANTI-INFECTIVE PRODUCTS ANALYZING MARKET DYNAMICS
9.1 OTC Anti-Infective Products Industry Trends
9.2 OTC Anti-Infective Products Industry Drivers
9.3 OTC Anti-Infective Products Industry Opportunities and Challenges
9.4 OTC Anti-Infective Products Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global OTC Anti-Infective Products Market Size (2018-2029) & (US$ Million)
2.2.2 Global OTC Anti-Infective Products Sales (2018-2029)
2.2.3 Global OTC Anti-Infective Products Market Average Price (2018-2029)
2.3 OTC Anti-Infective Products by Type
2.3.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 Antifungal
1.2.3 Antibacterial
1.2.4 Antiviral
1.2.5 Antiseptics
1.2.6 Others
2.4 OTC Anti-Infective Products by Sales Channel
2.4.1 Market Value Comparison by Sales Channel (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 Hospital Pharmacies
2.4.3 Retail Pharmacies
2.4.4 Online Pharmacies
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global OTC Anti-Infective Products Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global OTC Anti-Infective Products Sales (M Units) of Manufacturers (2018-2023)
3.3 Global OTC Anti-Infective Products Revenue of Manufacturers (2018-2023)
3.4 Global OTC Anti-Infective Products Average Price by Manufacturers (2018-2023)
3.5 Global OTC Anti-Infective Products Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of OTC Anti-Infective Products, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of OTC Anti-Infective Products, Product Type & Application
3.8 Global Manufacturers of OTC Anti-Infective Products, Date of Enter into This Industry
3.9 Global OTC Anti-Infective Products Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Bayer
4.1.1 Bayer Company Information
4.1.2 Bayer Business Overview
4.1.3 Bayer OTC Anti-Infective Products Sales, Revenue and Gross Margin (2018-2023)
4.1.4 Bayer OTC Anti-Infective Products Product Portfolio
4.1.5 Bayer Recent Developments
4.2 GSK
4.2.1 GSK Company Information
4.2.2 GSK Business Overview
4.2.3 GSK OTC Anti-Infective Products Sales, Revenue and Gross Margin (2018-2023)
4.2.4 GSK OTC Anti-Infective Products Product Portfolio
4.2.5 GSK Recent Developments
4.3 Teva
4.3.1 Teva Company Information
4.3.2 Teva Business Overview
4.3.3 Teva OTC Anti-Infective Products Sales, Revenue and Gross Margin (2018-2023)
4.3.4 Teva OTC Anti-Infective Products Product Portfolio
4.3.5 Teva Recent Developments
4.4 Johnson & Johnson
4.4.1 Johnson & Johnson Company Information
4.4.2 Johnson & Johnson Business Overview
4.4.3 Johnson & Johnson OTC Anti-Infective Products Sales, Revenue and Gross Margin (2018-2023)
4.4.4 Johnson & Johnson OTC Anti-Infective Products Product Portfolio
4.4.5 Johnson & Johnson Recent Developments
4.5 NOVARTIS
4.5.1 NOVARTIS Company Information
4.5.2 NOVARTIS Business Overview
4.5.3 NOVARTIS OTC Anti-Infective Products Sales, Revenue and Gross Margin (2018-2023)
6.5.4 NOVARTIS OTC Anti-Infective Products Product Portfolio
6.5.5 NOVARTIS Recent Developments
4.6 MYLAN
4.6.1 MYLAN Company Information
4.6.2 MYLAN Business Overview
4.6.3 MYLAN OTC Anti-Infective Products Sales, Revenue and Gross Margin (2018-2023)
4.6.4 MYLAN OTC Anti-Infective Products Product Portfolio
4.6.5 MYLAN Recent Developments
4.7 Sun Pharma
4.7.1 Sun Pharma Company Information
4.7.2 Sun Pharma Business Overview
4.7.3 Sun Pharma OTC Anti-Infective Products Sales, Revenue and Gross Margin (2018-2023)
4.7.4 Sun Pharma OTC Anti-Infective Products Product Portfolio
4.7.5 Sun Pharma Recent Developments
6.8 CR SANJIU
4.8.1 CR SANJIU Company Information
4.8.2 CR SANJIU Business Overview
4.8.3 CR SANJIU OTC Anti-Infective Products Sales, Revenue and Gross Margin (2018-2023)
4.8.4 CR SANJIU OTC Anti-Infective Products Product Portfolio
4.8.5 CR SANJIU Recent Developments
4.9 Cipla
4.9.1 Cipla Company Information
4.9.2 Cipla Business Overview
4.9.3 Cipla OTC Anti-Infective Products Sales, Revenue and Gross Margin (2018-2023)
4.9.4 Cipla OTC Anti-Infective Products Product Portfolio
4.9.5 Cipla Recent Developments
4.10 Lingrui
4.10.1 Lingrui Company Information
4.10.2 Lingrui Business Overview
4.10.3 Lingrui OTC Anti-Infective Products Sales, Revenue and Gross Margin (2018-2023)
4.10.4 Lingrui OTC Anti-Infective Products Product Portfolio
4.10.5 Lingrui Recent Developments
5 GLOBAL OTC ANTI-INFECTIVE PRODUCTS MARKET SCENARIO BY REGION
5.1 Global OTC Anti-Infective Products Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global OTC Anti-Infective Products Sales by Region: 2018-2029
5.2.1 Global OTC Anti-Infective Products Sales by Region: 2018-2023
5.2.2 Global OTC Anti-Infective Products Sales by Region: 2024-2029
5.3 Global OTC Anti-Infective Products Revenue by Region: 2018-2029
5.3.1 Global OTC Anti-Infective Products Revenue by Region: 2018-2023
5.3.2 Global OTC Anti-Infective Products Revenue by Region: 2024-2029
5.4 North America OTC Anti-Infective Products Market Facts & Figures by Country
5.4.1 North America OTC Anti-Infective Products Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America OTC Anti-Infective Products Sales by Country (2018-2029)
5.4.3 North America OTC Anti-Infective Products Revenue by Country (2018-2029)
5.4.4 United States
5.4.5 Canada
5.5 Europe OTC Anti-Infective Products Market Facts & Figures by Country
5.5.1 Europe OTC Anti-Infective Products Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe OTC Anti-Infective Products Sales by Country (2018-2029)
5.5.3 Europe OTC Anti-Infective Products Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific OTC Anti-Infective Products Market Facts & Figures by Country
5.6.1 Asia Pacific OTC Anti-Infective Products Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific OTC Anti-Infective Products Sales by Country (2018-2029)
5.6.3 Asia Pacific OTC Anti-Infective Products Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America OTC Anti-Infective Products Market Facts & Figures by Country
5.7.1 Latin America OTC Anti-Infective Products Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America OTC Anti-Infective Products Sales by Country (2018-2029)
5.7.3 Latin America OTC Anti-Infective Products Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa OTC Anti-Infective Products Market Facts & Figures by Country
5.8.1 Middle East and Africa OTC Anti-Infective Products Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa OTC Anti-Infective Products Sales by Country (2018-2029)
5.8.3 Middle East and Africa OTC Anti-Infective Products Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global OTC Anti-Infective Products Sales by Type (2018-2029)
6.1.1 Global OTC Anti-Infective Products Sales by Type (2018-2029) & (M Units)
6.1.2 Global OTC Anti-Infective Products Sales Market Share by Type (2018-2029)
6.2 Global OTC Anti-Infective Products Revenue by Type (2018-2029)
6.2.1 Global OTC Anti-Infective Products Sales by Type (2018-2029) & (US$ Million)
6.2.2 Global OTC Anti-Infective Products Revenue Market Share by Type (2018-2029)
6.3 Global OTC Anti-Infective Products Price by Type (2018-2029)
7 SEGMENT BY SALES CHANNEL
7.1 Global OTC Anti-Infective Products Sales by Sales Channel (2018-2029)
7.1.1 Global OTC Anti-Infective Products Sales by Sales Channel (2018-2029) & (M Units)
7.1.2 Global OTC Anti-Infective Products Sales Market Share by Sales Channel (2018-2029)
7.2 Global OTC Anti-Infective Products Revenue by Sales Channel (2018-2029)
6.2.1 Global OTC Anti-Infective Products Sales by Sales Channel (2018-2029) & (US$ Million)
6.2.2 Global OTC Anti-Infective Products Revenue Market Share by Sales Channel (2018-2029)
7.3 Global OTC Anti-Infective Products Price by Sales Channel (2018-2029)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 OTC Anti-Infective Products Value Chain Analysis
8.1.1 OTC Anti-Infective Products Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 OTC Anti-Infective Products Production Mode & Process
8.2 OTC Anti-Infective Products Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 OTC Anti-Infective Products Distributors
8.2.3 OTC Anti-Infective Products Customers
9 GLOBAL OTC ANTI-INFECTIVE PRODUCTS ANALYZING MARKET DYNAMICS
9.1 OTC Anti-Infective Products Industry Trends
9.2 OTC Anti-Infective Products Industry Drivers
9.3 OTC Anti-Infective Products Industry Opportunities and Challenges
9.4 OTC Anti-Infective Products Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Sales Channel (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global OTC Anti-Infective Products Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global OTC Anti-Infective Products Sales (M Units) of Manufacturers (2018-2023)
Table 7. Global OTC Anti-Infective Products Sales Market Share by Manufacturers (2018-2023)
Table 8. Global OTC Anti-Infective Products Revenue of Manufacturers (2018-2023)
Table 9. Global OTC Anti-Infective Products Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market OTC Anti-Infective Products Average Price (US$/Unit) of Manufacturers (2018-2023)
Table 11. Global OTC Anti-Infective Products Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of OTC Anti-Infective Products, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global OTC Anti-Infective Products by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Bayer Company Information
Table 17. Bayer Business Overview
Table 18. Bayer OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 19. Bayer OTC Anti-Infective Products Product Portfolio
Table 20. Bayer Recent Developments
Table 21. GSK Company Information
Table 22. GSK Business Overview
Table 23. GSK OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 24. GSK OTC Anti-Infective Products Product Portfolio
Table 25. GSK Recent Developments
Table 26. Teva Company Information
Table 27. Teva Business Overview
Table 28. Teva OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 29. Teva OTC Anti-Infective Products Product Portfolio
Table 30. Teva Recent Developments
Table 31. Johnson & Johnson Company Information
Table 32. Johnson & Johnson Business Overview
Table 33. Johnson & Johnson OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 34. Johnson & Johnson OTC Anti-Infective Products Product Portfolio
Table 35. Johnson & Johnson Recent Developments
Table 36. NOVARTIS Company Information
Table 37. NOVARTIS Business Overview
Table 38. NOVARTIS OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 39. NOVARTIS OTC Anti-Infective Products Product Portfolio
Table 40. NOVARTIS Recent Developments
Table 41. MYLAN Company Information
Table 42. MYLAN Business Overview
Table 43. MYLAN OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 44. MYLAN OTC Anti-Infective Products Product Portfolio
Table 45. MYLAN Recent Developments
Table 46. Sun Pharma Company Information
Table 47. Sun Pharma Business Overview
Table 48. Sun Pharma OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 49. Sun Pharma OTC Anti-Infective Products Product Portfolio
Table 50. Sun Pharma Recent Developments
Table 51. CR SANJIU Company Information
Table 52. CR SANJIU Business Overview
Table 53. CR SANJIU OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 54. CR SANJIU OTC Anti-Infective Products Product Portfolio
Table 55. CR SANJIU Recent Developments
Table 56. Cipla Company Information
Table 57. Cipla Business Overview
Table 58. Cipla OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 59. Cipla OTC Anti-Infective Products Product Portfolio
Table 60. Cipla Recent Developments
Table 61. Lingrui Company Information
Table 62. Lingrui Business Overview
Table 63. Lingrui OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 64. Lingrui OTC Anti-Infective Products Product Portfolio
Table 65. Lingrui Recent Developments
Table 66. Global OTC Anti-Infective Products Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 67. Global OTC Anti-Infective Products Sales by Region (2018-2023) & (M Units)
Table 68. Global OTC Anti-Infective Products Sales Market Share by Region (2018-2023)
Table 69. Global OTC Anti-Infective Products Sales by Region (2024-2029) & (M Units)
Table 70. Global OTC Anti-Infective Products Sales Market Share by Region (2024-2029)
Table 71. Global OTC Anti-Infective Products Revenue by Region (2018-2023) & (US$ Million)
Table 72. Global OTC Anti-Infective Products Revenue Market Share by Region (2018-2023)
Table 73. Global OTC Anti-Infective Products Revenue by Region (2024-2029) & (US$ Million)
Table 74. Global OTC Anti-Infective Products Revenue Market Share by Region (2024-2029)
Table 75. North America OTC Anti-Infective Products Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 76. North America OTC Anti-Infective Products Sales by Country (2018-2023) & (M Units)
Table 77. North America OTC Anti-Infective Products Sales by Country (2024-2029) & (M Units)
Table 78. North America OTC Anti-Infective Products Revenue by Country (2018-2023) & (US$ Million)
Table 79. North America OTC Anti-Infective Products Revenue by Country (2024-2029) & (US$ Million)
Table 80. Europe OTC Anti-Infective Products Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 81. Europe OTC Anti-Infective Products Sales by Country (2018-2023) & (M Units)
Table 82. Europe OTC Anti-Infective Products Sales by Country (2024-2029) & (M Units)
Table 83. Europe OTC Anti-Infective Products Revenue by Country (2018-2023) & (US$ Million)
Table 84. Europe OTC Anti-Infective Products Revenue by Country (2024-2029) & (US$ Million)
Table 85. Asia Pacific OTC Anti-Infective Products Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 86. Asia Pacific OTC Anti-Infective Products Sales by Country (2018-2023) & (M Units)
Table 87. Asia Pacific OTC Anti-Infective Products Sales by Country (2024-2029) & (M Units)
Table 88. Asia Pacific OTC Anti-Infective Products Revenue by Country (2018-2023) & (US$ Million)
Table 89. Asia Pacific OTC Anti-Infective Products Revenue by Country (2024-2029) & (US$ Million)
Table 90. Latin America OTC Anti-Infective Products Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Latin America OTC Anti-Infective Products Sales by Country (2018-2023) & (M Units)
Table 92. Latin America OTC Anti-Infective Products Sales by Country (2024-2029) & (M Units)
Table 93. Latin America OTC Anti-Infective Products Revenue by Country (2018-2023) & (US$ Million)
Table 94. Latin America OTC Anti-Infective Products Revenue by Country (2024-2029) & (US$ Million)
Table 95. Middle East and Africa OTC Anti-Infective Products Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 96. Middle East and Africa OTC Anti-Infective Products Sales by Country (2018-2023) & (M Units)
Table 97. Middle East and Africa OTC Anti-Infective Products Sales by Country (2024-2029) & (M Units)
Table 98. Middle East and Africa OTC Anti-Infective Products Revenue by Country (2018-2023) & (US$ Million)
Table 99. Middle East and Africa OTC Anti-Infective Products Revenue by Country (2024-2029) & (US$ Million)
Table 100. Global OTC Anti-Infective Products Sales by Type (2018-2023) & (M Units)
Table 101. Global OTC Anti-Infective Products Sales by Type (2024-2029) & (M Units)
Table 102. Global OTC Anti-Infective Products Sales Market Share by Type (2018-2023)
Table 103. Global OTC Anti-Infective Products Sales Market Share by Type (2024-2029)
Table 104. Global OTC Anti-Infective Products Revenue by Type (2018-2023) & (US$ Million)
Table 105. Global OTC Anti-Infective Products Revenue by Type (2024-2029) & (US$ Million)
Table 106. Global OTC Anti-Infective Products Revenue Market Share by Type (2018-2023)
Table 107. Global OTC Anti-Infective Products Revenue Market Share by Type (2024-2029)
Table 108. Global OTC Anti-Infective Products Price by Type (2018-2023) & (US$/Unit)
Table 109. Global OTC Anti-Infective Products Price by Type (2024-2029) & (US$/Unit)
Table 110. Global OTC Anti-Infective Products Sales by Sales Channel (2018-2023) & (M Units)
Table 111. Global OTC Anti-Infective Products Sales by Sales Channel (2024-2029) & (M Units)
Table 112. Global OTC Anti-Infective Products Sales Market Share by Sales Channel (2018-2023)
Table 113. Global OTC Anti-Infective Products Sales Market Share by Sales Channel (2024-2029)
Table 114. Global OTC Anti-Infective Products Revenue by Sales Channel (2018-2023) & (US$ Million)
Table 115. Global OTC Anti-Infective Products Revenue by Sales Channel (2024-2029) & (US$ Million)
Table 116. Global OTC Anti-Infective Products Revenue Market Share by Sales Channel (2018-2023)
Table 117. Global OTC Anti-Infective Products Revenue Market Share by Sales Channel (2024-2029)
Table 118. Global OTC Anti-Infective Products Price by Sales Channel (2018-2023) & (US$/Unit)
Table 119. Global OTC Anti-Infective Products Price by Sales Channel (2024-2029) & (US$/Unit)
Table 120. Key Raw Materials
Table 121. Raw Materials Key Suppliers
Table 122. OTC Anti-Infective Products Distributors List
Table 123. OTC Anti-Infective Products Customers List
Table 124. OTC Anti-Infective Products Industry Trends
Table 125. OTC Anti-Infective Products Industry Drivers
Table 126. OTC Anti-Infective Products Industry Restraints
Table 127. Authors List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Sales Channel (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global OTC Anti-Infective Products Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global OTC Anti-Infective Products Sales (M Units) of Manufacturers (2018-2023)
Table 7. Global OTC Anti-Infective Products Sales Market Share by Manufacturers (2018-2023)
Table 8. Global OTC Anti-Infective Products Revenue of Manufacturers (2018-2023)
Table 9. Global OTC Anti-Infective Products Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market OTC Anti-Infective Products Average Price (US$/Unit) of Manufacturers (2018-2023)
Table 11. Global OTC Anti-Infective Products Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of OTC Anti-Infective Products, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global OTC Anti-Infective Products by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Bayer Company Information
Table 17. Bayer Business Overview
Table 18. Bayer OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 19. Bayer OTC Anti-Infective Products Product Portfolio
Table 20. Bayer Recent Developments
Table 21. GSK Company Information
Table 22. GSK Business Overview
Table 23. GSK OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 24. GSK OTC Anti-Infective Products Product Portfolio
Table 25. GSK Recent Developments
Table 26. Teva Company Information
Table 27. Teva Business Overview
Table 28. Teva OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 29. Teva OTC Anti-Infective Products Product Portfolio
Table 30. Teva Recent Developments
Table 31. Johnson & Johnson Company Information
Table 32. Johnson & Johnson Business Overview
Table 33. Johnson & Johnson OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 34. Johnson & Johnson OTC Anti-Infective Products Product Portfolio
Table 35. Johnson & Johnson Recent Developments
Table 36. NOVARTIS Company Information
Table 37. NOVARTIS Business Overview
Table 38. NOVARTIS OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 39. NOVARTIS OTC Anti-Infective Products Product Portfolio
Table 40. NOVARTIS Recent Developments
Table 41. MYLAN Company Information
Table 42. MYLAN Business Overview
Table 43. MYLAN OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 44. MYLAN OTC Anti-Infective Products Product Portfolio
Table 45. MYLAN Recent Developments
Table 46. Sun Pharma Company Information
Table 47. Sun Pharma Business Overview
Table 48. Sun Pharma OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 49. Sun Pharma OTC Anti-Infective Products Product Portfolio
Table 50. Sun Pharma Recent Developments
Table 51. CR SANJIU Company Information
Table 52. CR SANJIU Business Overview
Table 53. CR SANJIU OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 54. CR SANJIU OTC Anti-Infective Products Product Portfolio
Table 55. CR SANJIU Recent Developments
Table 56. Cipla Company Information
Table 57. Cipla Business Overview
Table 58. Cipla OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 59. Cipla OTC Anti-Infective Products Product Portfolio
Table 60. Cipla Recent Developments
Table 61. Lingrui Company Information
Table 62. Lingrui Business Overview
Table 63. Lingrui OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 64. Lingrui OTC Anti-Infective Products Product Portfolio
Table 65. Lingrui Recent Developments
Table 66. Global OTC Anti-Infective Products Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 67. Global OTC Anti-Infective Products Sales by Region (2018-2023) & (M Units)
Table 68. Global OTC Anti-Infective Products Sales Market Share by Region (2018-2023)
Table 69. Global OTC Anti-Infective Products Sales by Region (2024-2029) & (M Units)
Table 70. Global OTC Anti-Infective Products Sales Market Share by Region (2024-2029)
Table 71. Global OTC Anti-Infective Products Revenue by Region (2018-2023) & (US$ Million)
Table 72. Global OTC Anti-Infective Products Revenue Market Share by Region (2018-2023)
Table 73. Global OTC Anti-Infective Products Revenue by Region (2024-2029) & (US$ Million)
Table 74. Global OTC Anti-Infective Products Revenue Market Share by Region (2024-2029)
Table 75. North America OTC Anti-Infective Products Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 76. North America OTC Anti-Infective Products Sales by Country (2018-2023) & (M Units)
Table 77. North America OTC Anti-Infective Products Sales by Country (2024-2029) & (M Units)
Table 78. North America OTC Anti-Infective Products Revenue by Country (2018-2023) & (US$ Million)
Table 79. North America OTC Anti-Infective Products Revenue by Country (2024-2029) & (US$ Million)
Table 80. Europe OTC Anti-Infective Products Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 81. Europe OTC Anti-Infective Products Sales by Country (2018-2023) & (M Units)
Table 82. Europe OTC Anti-Infective Products Sales by Country (2024-2029) & (M Units)
Table 83. Europe OTC Anti-Infective Products Revenue by Country (2018-2023) & (US$ Million)
Table 84. Europe OTC Anti-Infective Products Revenue by Country (2024-2029) & (US$ Million)
Table 85. Asia Pacific OTC Anti-Infective Products Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 86. Asia Pacific OTC Anti-Infective Products Sales by Country (2018-2023) & (M Units)
Table 87. Asia Pacific OTC Anti-Infective Products Sales by Country (2024-2029) & (M Units)
Table 88. Asia Pacific OTC Anti-Infective Products Revenue by Country (2018-2023) & (US$ Million)
Table 89. Asia Pacific OTC Anti-Infective Products Revenue by Country (2024-2029) & (US$ Million)
Table 90. Latin America OTC Anti-Infective Products Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Latin America OTC Anti-Infective Products Sales by Country (2018-2023) & (M Units)
Table 92. Latin America OTC Anti-Infective Products Sales by Country (2024-2029) & (M Units)
Table 93. Latin America OTC Anti-Infective Products Revenue by Country (2018-2023) & (US$ Million)
Table 94. Latin America OTC Anti-Infective Products Revenue by Country (2024-2029) & (US$ Million)
Table 95. Middle East and Africa OTC Anti-Infective Products Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 96. Middle East and Africa OTC Anti-Infective Products Sales by Country (2018-2023) & (M Units)
Table 97. Middle East and Africa OTC Anti-Infective Products Sales by Country (2024-2029) & (M Units)
Table 98. Middle East and Africa OTC Anti-Infective Products Revenue by Country (2018-2023) & (US$ Million)
Table 99. Middle East and Africa OTC Anti-Infective Products Revenue by Country (2024-2029) & (US$ Million)
Table 100. Global OTC Anti-Infective Products Sales by Type (2018-2023) & (M Units)
Table 101. Global OTC Anti-Infective Products Sales by Type (2024-2029) & (M Units)
Table 102. Global OTC Anti-Infective Products Sales Market Share by Type (2018-2023)
Table 103. Global OTC Anti-Infective Products Sales Market Share by Type (2024-2029)
Table 104. Global OTC Anti-Infective Products Revenue by Type (2018-2023) & (US$ Million)
Table 105. Global OTC Anti-Infective Products Revenue by Type (2024-2029) & (US$ Million)
Table 106. Global OTC Anti-Infective Products Revenue Market Share by Type (2018-2023)
Table 107. Global OTC Anti-Infective Products Revenue Market Share by Type (2024-2029)
Table 108. Global OTC Anti-Infective Products Price by Type (2018-2023) & (US$/Unit)
Table 109. Global OTC Anti-Infective Products Price by Type (2024-2029) & (US$/Unit)
Table 110. Global OTC Anti-Infective Products Sales by Sales Channel (2018-2023) & (M Units)
Table 111. Global OTC Anti-Infective Products Sales by Sales Channel (2024-2029) & (M Units)
Table 112. Global OTC Anti-Infective Products Sales Market Share by Sales Channel (2018-2023)
Table 113. Global OTC Anti-Infective Products Sales Market Share by Sales Channel (2024-2029)
Table 114. Global OTC Anti-Infective Products Revenue by Sales Channel (2018-2023) & (US$ Million)
Table 115. Global OTC Anti-Infective Products Revenue by Sales Channel (2024-2029) & (US$ Million)
Table 116. Global OTC Anti-Infective Products Revenue Market Share by Sales Channel (2018-2023)
Table 117. Global OTC Anti-Infective Products Revenue Market Share by Sales Channel (2024-2029)
Table 118. Global OTC Anti-Infective Products Price by Sales Channel (2018-2023) & (US$/Unit)
Table 119. Global OTC Anti-Infective Products Price by Sales Channel (2024-2029) & (US$/Unit)
Table 120. Key Raw Materials
Table 121. Raw Materials Key Suppliers
Table 122. OTC Anti-Infective Products Distributors List
Table 123. OTC Anti-Infective Products Customers List
Table 124. OTC Anti-Infective Products Industry Trends
Table 125. OTC Anti-Infective Products Industry Drivers
Table 126. OTC Anti-Infective Products Industry Restraints
Table 127. Authors List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. OTC Anti-Infective ProductsProduct Picture
Figure 5. Global OTC Anti-Infective Products Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global OTC Anti-Infective Products Market Size (2018-2029) & (US$ Million)
Figure 7. Global OTC Anti-Infective Products Sales (2018-2029) & (M Units)
Figure 8. Global OTC Anti-Infective Products Average Price (US$/Unit) & (2018-2029)
Figure 9. Antifungal Product Picture
Figure 10. Antibacterial Product Picture
Figure 11. Antiviral Product Picture
Figure 12. Antiseptics Product Picture
Figure 13. Others Product Picture
Figure 14. Hospital Pharmacies Product Picture
Figure 15. Retail Pharmacies Product Picture
Figure 16. Online Pharmacies Product Picture
Figure 17. Global OTC Anti-Infective Products Revenue Share by Manufacturers in 2022
Figure 18. Global Manufacturers of OTC Anti-Infective Products, Manufacturing Sites & Headquarters
Figure 19. Global Manufacturers of OTC Anti-Infective Products, Date of Enter into This Industry
Figure 20. Global Top 5 and 10 OTC Anti-Infective Products Players Market Share by Revenue in 2022
Figure 21. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 22. Global OTC Anti-Infective Products Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. Global OTC Anti-Infective Products Sales by Region in 2022
Figure 24. Global OTC Anti-Infective Products Revenue by Region in 2022
Figure 25. North America OTC Anti-Infective Products Market Size by Country in 2022
Figure 26. North America OTC Anti-Infective Products Sales Market Share by Country (2018-2029)
Figure 27. North America OTC Anti-Infective Products Revenue Market Share by Country (2018-2029)
Figure 28. United States OTC Anti-Infective Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Canada OTC Anti-Infective Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Europe OTC Anti-Infective Products Market Size by Country in 2022
Figure 31. Europe OTC Anti-Infective Products Sales Market Share by Country (2018-2029)
Figure 32. Europe OTC Anti-Infective Products Revenue Market Share by Country (2018-2029)
Figure 33. Germany OTC Anti-Infective Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. France OTC Anti-Infective Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. U.K. OTC Anti-Infective Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Italy OTC Anti-Infective Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Russia OTC Anti-Infective Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Asia Pacific OTC Anti-Infective Products Market Size by Country in 2022
Figure 39. Asia Pacific OTC Anti-Infective Products Sales Market Share by Country (2018-2029)
Figure 40. Asia Pacific OTC Anti-Infective Products Revenue Market Share by Country (2018-2029)
Figure 41. China OTC Anti-Infective Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Japan OTC Anti-Infective Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. South Korea OTC Anti-Infective Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. India OTC Anti-Infective Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Australia OTC Anti-Infective Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. China Taiwan OTC Anti-Infective Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Indonesia OTC Anti-Infective Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Thailand OTC Anti-Infective Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Malaysia OTC Anti-Infective Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Latin America OTC Anti-Infective Products Market Size by Country in 2022
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. OTC Anti-Infective ProductsProduct Picture
Figure 5. Global OTC Anti-Infective Products Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global OTC Anti-Infective Products Market Size (2018-2029) & (US$ Million)
Figure 7. Global OTC Anti-Infective Products Sales (2018-2029) & (M Units)
Figure 8. Global OTC Anti-Infective Products Average Price (US$/Unit) & (2018-2029)
Figure 9. Antifungal Product Picture
Figure 10. Antibacterial Product Picture
Figure 11. Antiviral Product Picture
Figure 12. Antiseptics Product Picture
Figure 13. Others Product Picture
Figure 14. Hospital Pharmacies Product Picture
Figure 15. Retail Pharmacies Product Picture
Figure 16. Online Pharmacies Product Picture
Figure 17. Global OTC Anti-Infective Products Revenue Share by Manufacturers in 2022
Figure 18. Global Manufacturers of OTC Anti-Infective Products, Manufacturing Sites & Headquarters
Figure 19. Global Manufacturers of OTC Anti-Infective Products, Date of Enter into This Industry
Figure 20. Global Top 5 and 10 OTC Anti-Infective Products Players Market Share by Revenue in 2022
Figure 21. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 22. Global OTC Anti-Infective Products Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. Global OTC Anti-Infective Products Sales by Region in 2022
Figure 24. Global OTC Anti-Infective Products Revenue by Region in 2022
Figure 25. North America OTC Anti-Infective Products Market Size by Country in 2022
Figure 26. North America OTC Anti-Infective Products Sales Market Share by Country (2018-2029)
Figure 27. North America OTC Anti-Infective Products Revenue Market Share by Country (2018-2029)
Figure 28. United States OTC Anti-Infective Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Canada OTC Anti-Infective Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Europe OTC Anti-Infective Products Market Size by Country in 2022
Figure 31. Europe OTC Anti-Infective Products Sales Market Share by Country (2018-2029)
Figure 32. Europe OTC Anti-Infective Products Revenue Market Share by Country (2018-2029)
Figure 33. Germany OTC Anti-Infective Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. France OTC Anti-Infective Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. U.K. OTC Anti-Infective Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Italy OTC Anti-Infective Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Russia OTC Anti-Infective Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Asia Pacific OTC Anti-Infective Products Market Size by Country in 2022
Figure 39. Asia Pacific OTC Anti-Infective Products Sales Market Share by Country (2018-2029)
Figure 40. Asia Pacific OTC Anti-Infective Products Revenue Market Share by Country (2018-2029)
Figure 41. China OTC Anti-Infective Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Japan OTC Anti-Infective Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. South Korea OTC Anti-Infective Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. India OTC Anti-Infective Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Australia OTC Anti-Infective Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. China Taiwan OTC Anti-Infective Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Indonesia OTC Anti-Infective Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Thailand OTC Anti-Infective Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Malaysia OTC Anti-Infective Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Latin America OTC Anti-Infective Products Market Size by Country in 2022
